| 4/3/2025 | BKCVDDEMIGPV | Market Commentary: Junk: credit spreads blow out, secondary drops; Owens & Minor pares losses; Bausch falls
|
| 4/2/2025 | BKCVDDEMIGPV | Market Commentary: Owens & Minor prices; Patterson joins junk calendar; Bausch active; Organon lower
|
| 3/26/2025 | BKCVDDEMIGPV | Market Commentary: Chuck E. Cheese joins calendar; Bausch comes in; Starwood, goeasy lag
|
| 3/25/2025 | BKCVDDEMIGPV | Market Commentary: Bausch Health prices megadeal; calendar grows; EZCorp outperforms
|
| 3/25/2025 | BK | Market Commentary: Bausch Health, M6 Midstream break; CohnReznick, Vista Global modified; Novolex accelerated
|
| 3/25/2025 | BK | Bausch Health cuts term B to $3 billion, firms at SOFR plus 625 bps
|
| 3/20/2025 | BKCADDHY | Moody's gives Bausch loans, notes Caa1
|
| 3/19/2025 | BKCVDDEMIGPV | Market Commentary: Bausch Health joins junk calendar, debt stack mixed on redemptions; Insulet shoots higher
|
| 3/19/2025 | BK | Market Commentary: Valvoline, LCI Industries, IFS break; Allwyn updates emerge; Bausch Health discloses talk
|
| 3/19/2025 | BK | Bausch Health launches $3.4 billion term B at SOFR plus 600-625 bps
|
| 3/19/2025 | BKCADDHY | S&P ups Bausch, rates loans, notes B
|
| 3/19/2025 | BKCADDHY | S&P hikes Bausch + Lomb
|
| 3/17/2025 | BKCVDDEMIGPV | Market Commentary: Novolex joins shadow calendar; secondary quiet but firm; Cornerstone tanks on earnings
|
| 3/17/2025 | BKCAHY | Bausch Health expected to bring $4 billion to $5 billion of notes, loans in mid-to-late March
|
| 2/28/2025 | BKCVDDEMIGPV | Market Commentary: Olin drives by; shadow calendar eyed; WEX flat; Celanese active ahead of anticipated offering
|
| 2/20/2025 | BKCVDDEMIGPV | Market Commentary: Amsted drives by with junk; First Quantum, Albertsons rise; funds add $1.21 billion
|
| 11/1/2024 | BK | Bausch + Lomb borrows $400 million in second incremental term loans
|
| 7/24/2024 | BKCADDHY | Bausch Health says it is not considering filing bankruptcy
|
| 4/18/2024 | BKCADDHY | S&P bumps up Bausch Health Cos.
|
| 10/3/2023 | BKDDHY | Fitch lowers Bausch Health debt
|
| 9/11/2023 | BKCAHY | Moody's gives Bausch+Lomb loan, notes B1
|
| 7/7/2023 | BK | Bausch Health unit gets $600 million revolver at SOFR plus 665 bps
|
| 7/7/2023 | BKCVDDEMIGPV | Market Commentary: Secondary firms; Sealed Air gains; Copeland improves; Bausch outperforms
|
| 2/28/2023 | BKCADDHY | S&P boosts Bausch Health
|
| 2/24/2023 | BKCADDHY | S&P lowers Bausch Health
|
| 1/6/2023 | BKCVDDEMIGPV | Market Commentary: Junk surges, closes week with strong gains; Ford hits 101-handle; DISH recoups losses
|
| 12/30/2022 | BKCVDDEMHY | Outlook 2023: Higher defaults in store across markets; distressed debt exchange leading cause
|
| 10/7/2022 | BKCADDHY | Fitch cuts, ups Bausch Health
|
| 10/4/2022 | BKCACVDDHY | S&P ups Bausch, rates notes B-, CCC
|
| 9/30/2022 | BKCACVDDHY | S&P slices Bausch Health Cos.
|
| 9/30/2022 | BKCACVDDHY | Moody's cuts some Bausch Health ratings
|
| 8/31/2022 | BKCVDDEMIGPV | Market Commentary: Royal Caribbean, Ford losses mount in junk trading; Bausch mixed on exchange offer
|
| 8/31/2022 | BKCADDHY | Fitch slashes Bausch Health
|
| 8/31/2022 | BKCADDHY | Moody's cuts Bausch Health
|
| 8/31/2022 | BKCADDHY | S&P drops Bausch Health to CC
|
| 8/24/2022 | BKCVDDEMIGPV | Market Commentary: FXI active in junkland; Bausch under pressure; Toledo sell-off continues
|
| 8/22/2022 | BKCVDDEMIGPV | Market Commentary: Junk bonds open week with losses; Ford, Royal Caribbean under water; Charter down again
|
| 8/22/2022 | BKCADDHY | Bausch Health internally transfers stock, explores strategic alternatives
|
| 8/9/2022 | BKBWCAHYLM | Bausch buys $481 million bonds at a discount; no debt due until 2025
|
| 8/3/2022 | BKCVHY | Fitch pares Bausch Health
|
| 8/1/2022 | BKCACVHY | S&P cuts Bausch Health
|
| 7/29/2022 | BKCACVHY | Moody's downgrades Bausch Health
|
| 5/31/2022 | BKCAHY | S&P cuts Bausch Health Cos.
|
| 5/13/2022 | BKCAHY | Moody's downgrades Bausch Health
|
| 5/10/2022 | BK | Bausch + Lomb, Bausch Health enter $1.48 billion of revolvers
|
| 4/20/2022 | BKCAHY | Fitch plans to rate Bausch + Lomb BB-, loan BB+
|
| 4/20/2022 | BKCAHY | Moody’s rates Bausch + Lomb loans Ba2
|
| 3/29/2022 | BK | Bausch Health to pay down $200 million under term loans
|
| 2/24/2022 | BKBWCAHYLM | Bausch Health de-levers to 6.5x, will de-lever subsidiaries as well
|
| 2/2/2022 | BKCVDDEMIGPV | Market Commentary: AMC, Mednax, Boyne sell new junk; volatility returns; Bausch gains; cruise lines improve
|
| 1/31/2022 | BKCVDDEMIGPV | Market Commentary: Calendar builds; secondary firms; Bausch, Embecta improve
|
| 1/28/2022 | BKCVDDEMIGPV | Market Commentary: ION, Covis on hold; volatile junk market ends day up, week down; athenahealth struggles
|
| 1/27/2022 | BK | Market Commentary: Crocs, Embecta, Intelsat, Bausch Health, TaylorMade, athenahealth, Inspire Brands break
|
| 1/27/2022 | BKCAHY | Moody's gives Bausch Health notes Ba3
|
| 1/27/2022 | BKCAHY | Fitch rates Bausch Health notes BB
|
| 1/27/2022 | BKCAHY | S&P assigns Bausch Health notes BB
|
| 1/27/2022 | BK | Bausch lifts spread on $2.5 billion term loan B to SOFR plus 525 bps
|
| 1/19/2022 | BK | Market Commentary: Griffon, Addison Group, NAB, Liberty Tire break; Arxada, System One changes surface
|
| 1/19/2022 | BK | Bausch launches $2.5 billion term loan B at SOFR plus 475-500 bps
|
| 1/18/2022 | BK | Market Commentary: Griffon tweaks deal; Vaco accelerates deadline; Embecta, Syniverse, Dessert reveal talk
|
| 1/18/2022 | BKCAHY | S&P rates Bausch loans BB
|
| 1/18/2022 | BKCAHY | Fitch rates Bausch facility BB
|
| 1/18/2022 | BKCAHY | Moody's rates Bausch Health loans Ba3
|
| 1/18/2022 | BK | Bausch Health to launch $2.5 billion term loan B on Wednesday
|
| 11/18/2021 | BKCAHY | Moody's alters Bausch Health view to negative
|
| 5/27/2021 | BKCVDDEMIGPV | Market Commentary: High yield: CQP prices; secondary quiet, unchanged; Park River on a par-handle
|
| 5/25/2021 | BKCVDDEMIGPV | Market Commentary: Junk market sells $4.29 billion; Bausch Health gains; Antero at a premium; Nielsen weakens
|
| 5/24/2021 | BKCVDDEMIGPV | Market Commentary: Primary prices $3.6 billion; forward calendar grows; Bausch unsecured tranches drop; Square active
|
| 5/24/2021 | BKCAHY | Fitch gives Bausch Health notes BB
|
| 5/24/2021 | BKCAHY | S&P assigns Bausch Health notes BB
|
| 5/24/2021 | BKCAHY | Moody's rates Bausch Health notes Ba2
|
| 5/5/2021 | BKCAHY | Fitch revises Bausch Health view to negative
|
| 5/4/2021 | BKCVDDEMIGPV | Market Commentary: High yield: Community Health prices; ION Trading gains; Bausch under pressure
|
| 5/4/2021 | BKCAHY | S&P alters Bausch Health view to negative
|
| 2/24/2021 | BKBWCAHY | Bausch repays $900 million debt in 2020, targets $1 billion for 2021
|
| 1/13/2021 | BKBWCAHY | Bausch Health aims to cut leverage via debt paydowns, higher EBITDA
|
| 12/30/2020 | BK | Bausch Health to repay $275 million more in secured term loans
|
| 12/24/2020 | BKCVDDEMIGPV | Market Commentary: Primary closes the books on 2020; liquidity at a standstill
|
| 12/1/2020 | BKBWCAHY | Bausch management seeks to cut leverage as company is ‘very levered’
|
| 11/19/2020 | BKCVDDEMIGPV | Market Commentary: Primary prices over $6 billion; Bausch in focus; Diamond Sports gains; funds up $490 million
|
| 11/18/2020 | BKCVDDEMIGPV | Market Commentary: Bausch Health megadeal, Syneos price; NRG in focus; MGM at a premium
|
| 11/18/2020 | BKCAHY | S&P assigns Bausch Health notes B
|
| 11/18/2020 | BKCAHY | Moody’s gives Bausch Health notes B3
|
| 11/18/2020 | BKCAHY | Fitch rates Bausch Health notes B
|
| 5/12/2020 | BKCVDDEMIGPV | Market Commentary: Viking Cruises, OneMain/Springleaf, Match, Radian price; Encompass adds-on
|
| 5/12/2020 | BK | Bausch to prepay amortization for 2022 under its existing term loans
|
| 5/11/2020 | BKCVDDEMIGPV | Market Commentary: Bausch Health, Lamar Media, PowerTeam price; Ford breaks par; Callon Petroleum gains
|
| 5/11/2020 | BKCAHY | S&P rates Bausch Health notes B
|
| 5/11/2020 | BKCAHY | Fitch rates Bausch Health notes B
|
| 5/11/2020 | BKCAHY | Moody’s rates Bausch Health notes B3
|
| 3/13/2020 | BK | Bausch Health to pay down about $100 million in term loans
|
| 3/2/2020 | BKCAHYLM | Bausch cancels plans for new notes, loan refinancing, redemption
|
| 2/21/2020 | BKCAHY | S&P gives Bausch Health loan, notes BB
|
| 2/20/2020 | BK | Moody's cuts Auris Luxembourg II
|
| 2/20/2020 | BKCAHY | Fitch rates Bausch Health Americas facility, notes BB
|
| 12/23/2019 | BKCVDDEMIGPV | Market Commentary: Cincinnati Bell skyrockets on buyout news; Calpine, Bausch, CenturyLink active
|
| 12/19/2019 | BKCVDDEMIGPV | Market Commentary: Calpine prices new offering, recent issues unchanged; Bausch active; Vivint, Rite Aid gain
|
| 12/18/2019 | BKCVDDEMIGPV | Market Commentary: Bausch Health’s new notes jump, outstanding notes trade down; Alliance Data flat; Intelsat gains
|
| 12/17/2019 | BKCVDDEMIGPV | Market Commentary: Alliance Data, Bausch Health, Qorvo add-on price; Archrock in focus; oil patch firms
|
| 11/4/2019 | BKBWCAHY | Bausch pays down debt in search of ‘more reasonable’ capital structure
|
| 10/1/2019 | BKCVDDEMIGPV | Market Commentary: Shutterfly prices, Alliant on tap; Bausch, U.S. Steel lower, WeWork sees respite
|
| 9/3/2019 | BK | Bausch Health to reduce debt by $200 million via paydown, redemption
|
| 7/29/2019 | BK | Bausch continues debt reduction with additional $100 million paydown
|
| 6/25/2019 | BK | Bausch to pay down another $100 million of term loan debt with cash
|
| 5/13/2019 | BKCVDDEMIGPV | Market Commentary: Eldorado on tap; Bausch Health weakens; Charter below par; Weatherford, Teva down
|
| 5/10/2019 | BKCVDDEMIGPV | Market Commentary: Bausch Health trades up, Century Communities, Charter lag; Tronox drops post-earnings
|
| 5/9/2019 | BKCVDDEMIGPV | Market Commentary: Bausch Health, Century Communities, Charter price; Virgin Media lags; funds lose $212 million
|
| 5/6/2019 | BKBWCAHY | Bausch Health retires $158 million debt in Q1, plans to boost EBITDA
|
| 2/25/2019 | BKCVDDEMIGPV | Market Commentary: Bausch trades up; Windstream mixed, Uniti gains on bankruptcy filing; Multi-Color jumps
|
| 2/25/2019 | BKCAHY | S&P rates Bausch Health
|
| 2/22/2019 | BKCAHY | Moody’s rates Bausch Health notes Ba2, B3
|
| 2/22/2019 | BKCAHY | Fitch rates Bausch Health notes BB-
|
| 1/29/2019 | BK | Bausch Health pays down $100 million more senior secured term loans
|
| 1/11/2019 | BKCVDDEMIGPV | Market Commentary: Dun & Bradstreet, Energizer on tap; Targa up; PG&E mixed; energy rally ends; Bausch down
|
| 1/8/2019 | BKCVDDEMIGPV | Market Commentary: Pacific Gas & Electric in focus; energy rally continues; Hornbeck, Bausch Health gain
|
| 1/4/2019 | BKCVDDEMIGPV | Market Commentary: Risk-on sentiment returns; CDX sees largest single-day gain in four years; energy outperforms
|
| 12/19/2018 | BK | Bausch Health to pay down $76 million more senior secured term loans
|
| 11/29/2018 | BKCVDDEMIGPV | Market Commentary: Mercer prices; McDermott rebound continues; Westcorp drops; Bausch improves
|
| 11/9/2018 | BKCAHY | S&P affirms Bausch Health
|
| 11/8/2018 | BKCADDHY | Moody's upgrades Bausch
|
| 11/8/2018 | BK | Valeant Pharmaceuticals talks $750 million term loan at 99-99.5 OID
|
| 9/11/2018 | BK | Bausch Health pays down $107 million of term loan, revolver debt
|
| 8/23/2018 | BKCADDHY | Moody’s ups Bausch SGL, changes view
|
| 5/8/2018 | BKBWCAHYLM | Valeant cuts debt by $6.9 billion since 2016; ‘more work to be done’
|
